Rodriguez-Rodriguez L - Search Results

1

Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma.

Runowicz CD, Wadler S, Rodriguez-Rodriguez L, Litwin P, Shaves M, O'Hanlan KA, Goldberg GL, Tomaino CT, Byrnes R. Runowicz CD, et al. Gynecol Oncol. 1989 Sep;34(3):395-401. doi: 10.1016/0090-8258(89)90180-7. Gynecol Oncol. 1989. PMID: 2767531

2

Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: review of the literature.

O'Hanlan KA, Goldberg GL, Jones JG, Runowicz CD, Ehrlich L, Rodriguez-Rodriguez L. O'Hanlan KA, et al. Gynecol Oncol. 1991 Nov;43(2):167-72. doi: 10.1016/0090-8258(91)90066-e. Gynecol Oncol. 1991. PMID: 1660433 Review.

3

Virulence of papillary endometrial carcinoma.

O'Hanlan KA, Levine PA, Harbatkin D, Feiner C, Goldberg GL, Jones JG, Rodriguez-Rodriguez L. O'Hanlan KA, et al. Gynecol Oncol. 1990 Apr;37(1):112-9. doi: 10.1016/0090-8258(90)90318-f. Gynecol Oncol. 1990. PMID: 2323606

4

Arterial embolization in the management of abdominal and retroperitoneal hemorrhage.

O'Hanlan KA, Trambert J, Rodriguez-Rodriguez L, Goldberg GL, Runowicz CD. O'Hanlan KA, et al. Gynecol Oncol. 1989 Aug;34(2):131-5. doi: 10.1016/0090-8258(89)90127-3. Gynecol Oncol. 1989. PMID: 2753420

5

Respiratory failure due to interstitial lung metastases of ovarian carcinoma reversed by chemotherapy.

Fernandez K, O'Hanlan KA, Rodriguez-Rodriguez L, Marino WD. Fernandez K, et al. Chest. 1991 Jun;99(6):1533-4. doi: 10.1378/chest.99.6.1533. Chest. 1991. PMID: 2036849

6

Prognostic value of CD44 expression in invasive squamous cell carcinoma of the vulva.

Rodríguez-Rodríguez L, Sancho-Torres I, Miller Watelet L, Gibbon DG, Comerci JT, Mesonero C. Rodríguez-Rodríguez L, et al. Gynecol Oncol. 1999 Oct;75(1):34-40. doi: 10.1006/gyno.1999.5560. Gynecol Oncol. 1999. PMID: 10502422

7

Clear cell carcinoma of the ovary: characterization of its CD44 isoform repertoire.

Sancho-Torres I, Mesonero C, Miller Watelet JL, Gibbon D, Rodríguez-Rodríguez L. Sancho-Torres I, et al. Gynecol Oncol. 2000 Nov;79(2):187-95. doi: 10.1006/gyno.2000.5938. Gynecol Oncol. 2000. PMID: 11063642 Free article.

8

CD44-9v and CD44-10v are potential molecular markers for squamous cell carcinoma of the vulva.

Rodríguez-Rodríguez L, Sancho-Torres I, Gibbon DG, Watelet LF, Mesonero C. Rodríguez-Rodríguez L, et al. J Soc Gynecol Investig. 2000 Jan-Feb;7(1):70-5. doi: 10.1016/s1071-5576(99)00045-3. J Soc Gynecol Investig. 2000. PMID: 10732319

9

Phase 2 trial of paclitaxel, 13-cis retinoic acid, and interferon alfa-2b in the treatment of advanced stage or recurrent cervical cancer.

Song M, DiPaola RS, Cracchiolo BM, Gibbon DG, Hellmann M, Nieves-Neira W, Vaidya A, Wagreich AR, Shih WJ, Rodriguez-Rodriguez L. Song M, et al. Int J Gynecol Cancer. 2014 Nov;24(9):1636-41. doi: 10.1097/IGC.0000000000000258. Int J Gynecol Cancer. 2014. PMID: 25304678 Free PMC article. Clinical Trial.

10

CD44 splice variant expression in clear cell carcinoma of the ovary.

Rodríguez-Rodríguez L, Sancho-Torres I, Leakey P, Gibbon DG, Comerci JT, Ludlow JW, Mesonero C. Rodríguez-Rodríguez L, et al. Gynecol Oncol. 1998 Nov;71(2):223-9. doi: 10.1006/gyno.1998.5108. Gynecol Oncol. 1998. PMID: 9826464 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page